Kidney Biopsy Market – Overview
Kidney biopsy, also known as renal biopsy is a procedure for obtaining a sample from kidney tissue for analysis. Kidney biopsy is used to diagnose kidney disease, monitor the effect of treatment, and determine whether the kidney transplant is working well or not. It consists of mainly two types; percutaneous biopsy and surgical biopsy. In a percutaneous biopsy, a needle is inserted into the kidney through the skin, while in the surgical biopsy, an incision is made in the skin near the kidney to take a tissue sample for examination.
As per the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), kidney disease is often referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. Chronic kidney disease (CKD) is a global health burden and a risk factor for cardiovascular disease (CVD). High blood pressure and diabetes are the main causes of CKD.
Increasing number of biopsy procedures and rising demand for new techniques for diagnosis of chronic diseases are the major drivers for the growth of the market. Additionally, increasing prevalence of kidney diseases and rising need for the better diagnostic and treatment methods drive the growth of the market. Established market players in the developed countries lead the globalization by offering new products and services to the developing countries and emerging economies. However, the high cost of diagnostic services may hinder the market growth during the forecast period. The global kidney biopsy market is expected to grow at a CAGR of ~5.2% during the forecast period, 2017-2023.
Get Sample Report with Current Market Trend here https://www.marketresearchfuture.com/sample_request/5309
Kidney Biopsy Market – Top Players
- Boston Scientific Corporation (U.S.)
- Cook Medical (U.S.)
- C R Bard, Inc. (U.S.)
- Devicor Medical Products Inc. (U.S.)
- Hologic Inc. (U.S.)
- Intact Medical Corporation (U.S.)
- Precision Biopsy, LLC
- Scion Medical Technologies LLC (U.S.)
- , Integra LifeSciences Corporation (U.S.)
- Creganna (U.S.)
- Focal Therapeutics, Inc. (U.S.)
- CareFusion (U.S.)
- Argon Medical Devices, Inc. (U.S.) and others.
Global Kidney Biopsy Market – Regional Analysis
The Americas kidney biopsy market is expected to show extensive growth owing to the increasing number of patient population with kidney diseases and technological advancement in the healthcare sector. Moreover, high healthcare spending and increasing government support for research & development will boost the market growth. Additionally, kidney disease is one of the major cause of mortality and morbidity in the Americas, thus boosting the market growth. According to the National Kidney Foundation, in 2016, nearly 82% patients in the U.S. were waiting for a kidney transplant, although a number of effective treatments are available in the market. Additionally, in 2016, over 2 million people underwent a kidney transplant or dialysis in the U.S.
In Europe, Germany, France, and the U.K are the major markets for kidney biopsy. The growth of the market in Europe is attributed to increasing use of diagnostic services in tertiary care centers, extensive research and development activities in the field of urology, and the emergence of new market players in the medical device industry.
Asia Pacific is the fastest growing kidney biopsy market across the globe owing vast progress of healthcare industries in major economies such as Japan, China, and India along with rising prevalence of chronic diseases such as diabetes, obesity, and high blood pressure. Japan holds a major share of the regional market due to the availability of technology, increasing healthcare spending, and increasing government initiatives for research. India is the hub of diabetic population in Asia Pacific region exhibiting extensive growth opportunities in the market.
The Middle East & Africa hold the least share of the global market due to limited availability of medical facilities. The United Arab Emirates, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market whereas, the African region is expected to witness a moderate growth.
Avail Stunning Discount on Customize Reports – https://www.marketresearchfuture.com/check-discount/5309
Global Kidney Biopsy Market – Segmentation
The global kidney biopsy market is segmented on the basis of type, indication and end user. On the basis of diagnosis, it is segmented into percutaneous biopsy and surgical biopsy. On the basis of indication, it is segmented into haematuria, kidney failure, proteinuria, kidney transplant, and others. Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.
Major TOC of Kidney Biopsy Market Research Report- Global Forecast till 2023
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Kidney Biopsy Market, By Type
6 Global Kidney Biopsy Market, By Diagnosis
7 Global Kidney Biopsy, By Indication
8 Global Kidney Biopsy, By End-user
9 Global Kidney Biopsy, By Region
7 Competitive Landscape
8 Company Profile
9 MRFR Conclusion
Have Any Query, Ask to Expert at https://www.marketresearchfuture.com/enquiry/5309
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar